Skip to content

Effect of respiratory rehabilitation for frail older patients with musculoskeletal disorders: a randomized controlled trial

Effect of respiratory rehabilitation for frail older patients with musculoskeletal disorders: a randomized controlled trial - Effect of respiratory rehabilitation for frail older patients with musculoskeletal disorders

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000027650
Enrollment
54
Registered
2017-06-06
Start date
2015-09-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

musculoskeletal disorders

Interventions

rehabilitation sessions that included respiratory rehabilitation two sessions a week, for 6 weeks. typical rehabilitation

Sponsors

University of Tsukuba Department of Medical Science and Welfare, Faculty of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: patients with musculoskeletal disorders; older persons certified as requiring support level or care leve,6 months since acute disease onset; Mini-Mental State Examination (MMSE) score over 21, absence of COPD or any other respiratory disease, and forced expiratory volume in 1 second (FEV1) of > 70.

Exclusion criteria

Exclusion criteria: moderate or severe cardiac disease (New York Heart Association Classification of III or IV), ischemic or hemorrhagic stroke, or neurodegenerative disease.

Design outcomes

Primary

MeasureTime frame
respiratory function,after six weeks

Secondary

MeasureTime frame
swallowing function, exercise tolerance, six-minute walk distance, thorax flexibility, muscle strength grip and abdominal, adl and qol

Countries

Japan

Contacts

Public ContactNaoki Maki

University of Tsukuba Graduate School of Comprehensive Human Sciences

naoki19760917@yahoo.co.jp080-2078-7135

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026